Blog
In autoimmune and inflammatory drug development, promising therapies frequently demonstrate strong efficacy in preclinical studies — yet fail later in development or in the clinic. While there are many reasons…
Choosing the right CRO-partner for your preclinical programs is more than a procurement decision. Preclinical data guide major investments, define development paths, and shape clinical strategy. The CRO you choose…
